Request Deal Involvement

AyurMaya Capital led a $401m Series D round in ElevateBio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

FGS Global

pr advisors

FGS Global

or

Principals

SOFTBANK VISION FUND 2

bidder

SOFTBANK VISION FUND 2

EMERSON COLLECTIVE LLC

bidder

EMERSON COLLECTIVE LLC

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

NOVO NORDISK

bidder

NOVO NORDISK

MPM CAPITAL

bidder

MPM CAPITAL

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

REDMILE GROUP

bidder

REDMILE GROUP

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

VERTEX VENTURES

bidder

VERTEX VENTURES

MATRIX CAPITAL MANAGEMENT

bidder

MATRIX CAPITAL MANAGEMENT

F2 VENTURES

bidder

F2 VENTURES

EDBI

bidder

EDBI

ELEVATEBIO LLC

target

ELEVATEBIO LLC

WOODLINE PARTNERS

bidder

WOODLINE PARTNERS

ITOCHU TECHNOLOGY VENTURES

bidder

ITOCHU TECHNOLOGY VENTURES

AYURMAYA CAPITAL

bidder

AYURMAYA CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - AyurMaya Capital led a $401m Series D round in ElevateBio.